Proton Therapy Systems Market
Global Market Study on Proton Therapy: Gastrointestinal Cancer Indication Segment Estimated to Record Market Attractiveness Index of 1.1 During 2016 - 2024
Proton Therapy Market Segmented By Single Room, Multiple Room Set up Type with Head and Neck Cancer, Brain Cancer, Sarcoma Pediatric Cancer, Gastro-intestinal Cancer, Prostate Cancer, Lung Cancer Indication
Global Market Study on Proton Therap Systems Market: Introduction
Proton therapy involves radiation devices having accelerated protons as a source of radiation. Proton therapy is used to kill all the viable cancer cells. In proton therapy particle accelerators are used to target the tumor with a beam of protons. The protons are charged particles that interfere with the DNA of the cells thus damaging them leading to cell death. Proton therapy devices are costly space consuming equipment that comprises accelerator, electro-magnets, gantry, nozzle and patient room.
In this report Persistence Market Research has categorized proton therapy devices into two types, namely single room center and multi room center. The single room center includes a proton therapy device equipped with only a single patient room whereas in case of multi room center a single proton therapy device is equipped with multiple patient rooms so that two or more patients can be simultaneously treated. The global proton therapy market has been segmented on the basis of set up type, indications and regions.
The global proton therapy market is projected to expand at a CAGR of 15.2% during the forecast period in terms of value. The global proton therapy market is estimated to be valued at nearly US$ 1,100 Mn in 2017 and is expected to reach nearly US$ 3,000 Mn by the end of 2024.
Find Out More about the Report Coverage
- Hitachi Ltd.
- Ion Beam Applications SA
- Mevion Medical Systems
- Mitsubishi Electric Corporation
- ProNova Solutions, LLC
- ProTom International
- Sumitomo Heavy Industries Ltd.
- Varian Medical Systems
Factors fueling the growth of the global proton therapy market
Growth of the global proton therapy market is mainly driven by increasing healthcare expenditure, increasing preference for advanced therapies by healthcare physicians, increasing adoption and increasing cancer prevalence. Another prominent growth driver is the faster uptake and access along with premium pricing.
Moreover, reimbursement rate, adoption rate and product pricing will define the future landscape of the global proton therapy market. However, pricing can become a deterrent in the global proton therapy market, especially when it comes to affordability of proton beam therapy devices by small hospital setups.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Based on application, the global proton therapy market is further segmented into Head & Neck cancer, Brain cancer, Sarcoma, Pediatric cancer, Gastro-intestinal cancer, Prostrate cancer and Lung cancer. Proton therapy applications are more inclined towards gastro-intestinal and lung cancer due to recommendations by healthcare professionals.
Moreover proton therapy is also considered to be comparatively safer in case of pediatric patients suffering from cancer. These applications are expected to drive the sales revenue for proton therapy devices over the forecast period.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Global Proton Therapy Market Attractiveness Analysis by Indication, 2016–2024
Lung Cancer indication segment is expected to be the most lucrative in the global proton therapy market with a market attractiveness index of 1.5. Gastrointestinal Cancer indication segment is projected to represent a market attractiveness index of 1.1. Sarcoma and Brain Cancer indication segments are forecast to represent a market attractiveness index of 0.8 and 0.4 respectively. Pediatric Cancer and Head and Neck Cancer indication segments are expected to represent a market attractiveness index of 0.8 and 1.3 respectively.
Explore Persistence Market Research’s expertise in promulgation of the business !
Resources and space required for setting up a proton therapy center is huge, and this is acting as a major restraint in the global proton therapy market
Proton beam therapy devices are very large in market size, and hence require a large space with dedicated area. The setup cost is exclusive of the device cost, which further adds to the total costing of the project. Hence allotting a large area for the device setup in the very close vicinity of a hospital becomes difficult to manage. This restraint is expected to hinder the sales growth of the global proton therapy market over the forecast period.
The Proton Therapy Market is segmented as follows:
By Set up Type
In the final section of the report, the global proton therapy market competitive landscape is included to provide report audiences with a dashboard view on the basis of categories of providers across the global proton therapy market and key differentiators.